Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
Séan Mc Cafferty, A.K.M. Ashiqul Haque, Aster Vandierendonck, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 2968-2983
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
Christin Schmidt, Barbara S. Schnierle
Pathogens (2023) Vol. 12, Iss. 1, pp. 138-138
Open Access | Times Cited: 37
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 9
Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza
Xiaole Cui, Pieter Vervaeke, Ya Gao, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19
Noelia Silva-Pilipich, Uxue Beloki, Laura Salaberry, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 318-318
Open Access | Times Cited: 7
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 19
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 5
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
Zhongjie Sun, Tingxin Wu, Huangfan Xie, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1103-1103
Open Access | Times Cited: 24
Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
Yalan Liu, Yuncheng Li, Qinxue Hu
Vaccines (2023) Vol. 11, Iss. 7, pp. 1142-1142
Open Access | Times Cited: 11
Key Essentials during the Transition from the Acute Phase of the COVID-19 Pandemic
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 10
In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 10
Overview of Nucleocapsid-Targeting Vaccines against COVID-19
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Vaccines (2023) Vol. 11, Iss. 12, pp. 1810-1810
Open Access | Times Cited: 10
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3
Engineered mRNA Delivery Systems for Biomedical Applications
Ji Wang, Haofang Zhu, Jingjing Gan, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 9
Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants
Hao Zhou, Ping Leng, Yang Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 15, pp. 2456-2470
Closed Access | Times Cited: 2
A Novel Self‐Amplifying mRNA with Decreased Cytotoxicity and Enhanced Protein Expression by Macrodomain Mutations
Yue Gong, Danni Yong, Gensheng Liu, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2
Alena Reguzova, Melanie Müller, Felix Pagallies, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, et al.
Advanced Therapeutics (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 7
Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes
Piotr Rzymski, Jacek Niedziela, Barbara Poniedziałek, et al.
Virology (2024) Vol. 596, pp. 110118-110118
Open Access | Times Cited: 2
A novel multi-antigenic parapoxvirus-based vaccine demonstrates efficacy in protecting hamsters and non-human primates against SARS-CoV-2 challenge
Alena Reguzova, Melanie Sigle, Felix Pagallies, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 6
STING and TLR9 agonists synergistically enhance the immunogenicity of SARS-CoV-2 subunit vaccine
Yang Li, Ziwei Chen, Xinyi Lu, et al.
Nano Research (2023) Vol. 16, Iss. 12, pp. 13322-13334
Closed Access | Times Cited: 6
A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
COVID (2023) Vol. 3, Iss. 9, pp. 1454-1472
Open Access | Times Cited: 5
In vitro mRNA‐S maternal vaccination induced altered immune regulation at the maternal‐fetal interface
Ananth Kumar Kammala, Madhuri Tatiparthy, Tilu Jain Thomas, et al.
American Journal of Reproductive Immunology (2024) Vol. 91, Iss. 5
Closed Access | Times Cited: 1
Immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2
Oinam Ningthemmani Singh, Umang Berry, Garima Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
Adrian Rice, Mohit S. Verma, Emily A. Voigt, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top